Tested Applications
| Positive IHC detected in | mouse colon tissue, human brain tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
| Positive IF/ICC detected in | HeLa cells |
Recommended dilution
| Application | Dilution |
|---|---|
| Immunohistochemistry (IHC) | IHC : 1:50-1:500 |
| Immunofluorescence (IF)/ICC | IF/ICC : 1:200-1:800 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
19699-1-AP targets LIMK1 in IHC, IF/ICC, IP, ELISA applications and shows reactivity with human, mouse samples.
| Tested Reactivity | human, mouse |
| Cited Reactivity | human, mouse |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
Peptide Predict reactive species |
| Full Name | LIM domain kinase 1 |
| Calculated Molecular Weight | 73 kDa |
| GenBank Accession Number | NM_002314 |
| Gene Symbol | LIMK1 |
| Gene ID (NCBI) | 3984 |
| RRID | AB_10696174 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | P53667 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
LIMK1,also named LIMK, belongs to the protein kinase superfamily and TKL Ser/Thr protein kinase family. LIMK1 is a protein kinase which regulates actin filament dynamics. Phosphorylates and inactivates the actin binding/depolymerizing factor cofilin, thereby stabilizing the actin cytoskeleton. Isoform 3 has a dominant negative effect on actin cytoskeletal changes. LIMK1 may be involved in brain development. The antibody has no cross-reaction with LIMK2.
Protocols
| Product Specific Protocols | |
|---|---|
| IF protocol for LIMK1 antibody 19699-1-AP | Download protocol |
| IHC protocol for LIMK1 antibody 19699-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The LIMK1 Polyclonal antibody (Cat# 19699-1-AP) has 11 citations published in journals including Cell Death & Disease, Cell Death Discovery, Clinical and Translational Medicine, Communications Biology, Oncology Reports, Molecular Carcinogenesis, Cancer Medicine, Tissue & Cell, Cell Biochemistry and Biophysics, and Central European Journal of Immunology. Research fields span cancer biology (hepatocellular, colorectal, breast, and cervical carcinoma), cytoskeleton regulation, cell migration and invasion, spermatogenesis, intestinal barrier function, adipogenic differentiation, and endoplasmic reticulum stress.
| Species | Application | Title |
|---|---|---|
Cell Death Dis Imbalanced LIMK1 and LIMK2 expression leads to human colorectal cancer progression and metastasis via promoting β-catenin nuclear translocation. | ||
Cell Death Dis Septin11 promotes hepatocellular carcinoma cell motility by activating RhoA to regulate cytoskeleton and cell adhesion | ||
Cell Death Discov FMNL2 suppresses cell migration and invasion of breast cancer: a reduction of cytoplasmic p27 via RhoA/LIMK/Cofilin pathway. | ||
Clin Transl Med Mechanism of Gzma-mediated GEF-H1 activation in intestinal epithelial cells leading to intestinal barrier dysfunction in sepsis | ||









